AgeX Therapeutics Inc (DELISTED) (AGE:DL)
11.10
-1.50
(-11.90%)
USD |
NYAM |
Mar 26, 16:00
12.18
+1.08
(+9.73%)
After-Hours: 20:00
AgeX Therapeutics Total Liabilities (Quarterly): 39.86M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 39.86M |
| June 30, 2023 | 34.57M |
| March 31, 2023 | 32.54M |
| December 31, 2022 | 20.56M |
| September 30, 2022 | 17.16M |
| June 30, 2022 | 15.84M |
| March 31, 2022 | 14.31M |
| December 31, 2021 | 15.03M |
| September 30, 2021 | 12.40M |
| June 30, 2021 | 10.84M |
| Date | Value |
|---|---|
| March 31, 2021 | 9.263M |
| December 31, 2020 | 9.321M |
| September 30, 2020 | 7.949M |
| June 30, 2020 | 6.879M |
| March 31, 2020 | 5.467M |
| December 31, 2019 | 4.825M |
| September 30, 2019 | 3.24M |
| June 30, 2019 | 2.85M |
| March 31, 2019 | 2.294M |
| December 31, 2018 | 2.44M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.85M
Minimum
Jun 2019
39.86M
Maximum
Sep 2023
14.60M
Average
11.62M
Median
Total Liabilities (Quarterly) Benchmarks
| Homology Medicines Inc (DELISTED) | 11.57M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.21M |
| Shareholders Equity (Quarterly) | -27.54M |
| Debt to Equity Ratio | -0.0806 |
| Current Ratio | 0.3561 |
| Net Debt Paydown Yield | 0.25% |